Among wealthy countries, the United States maintains the most substantial socioeconomic disparities in access to healthcare; however, these disparities were reduced when the Affordable Care Act (ACA) was implemented, according to a new study in Health Affairs.
Among wealthy countries, the United States maintains the most substantial socioeconomic disparities in access to healthcare; however, these disparities were reduced when the Affordable Care Act (ACA) was implemented, according to a new study in Health Affairs.
The study utilized national data from the 2011 to 2015 Behavioral Risk Factor Surveillance System to examine the changes in health insurance coverage associated with the ACA among varying socioeconomic levels and assessed based on an individuals’ income, education, employment status, and home ownership status.
The study found that among states that had expanded Medicaid by mid-2015 the coverage gap had decreased by 46% between residents of poor households (income of less than $25,000) and higher-income households (incomes more than $75,000). In nonexpansion states, the coverage gap also decreased but to a lesser degree (23%).
“Not only did access disparities fall in greater absolute terms in expansion states compared to nonexpansion states, but disparities were also smaller in expansion states in the first place,” the researchers noted. “States’ opting out of the ACA Medicaid expansion thus compounded preexisting access barriers for their poorer residents, leading to a geographic divergence in access for poor Americans.”
Despite the narrowed gaps that resulted from the implementation of the ACA, many Americans with incomes under $25,000 remained without coverage, with 35% uninsured in nonexpansion states and 21% in expansion states in 2015. This suggests the need for additional policies to further reduce the access disparities.
“President Trump and Republicans in Congress have promised to repeal and replace the ACA, with plans to reduce federal subsidies for Medicaid expansion and for low-income (but not Medicaid-eligible) insurance plans purchased on the exchanges,” the researchers noted. “Such an approach is likely to widen gaps in health care access between lower-income and better-off Americans, reversing gains observed under the ACA.”
More research is necessary to establish what access gains will contribute to improved health outcomes in order to demonstrate how the health disparities will alter as the policy environment changes.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More